← Leaderboards
Eva C Guinan
Dana-Farber Cancer Institute
$4,120,977
Attributed
$4,120,977
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2008–14$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,120,977 · 7
By mechanism
U19$2,026,948 · 2
R21$1,233,803 · 2
P50$852,726 · 1
R13$7,500 · 1
N01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- David G. Nathan$5,920,675
- Colin A Sieff$2,137,288
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignHuman SubjectIn VivoDoseResponseTransplant RejectionHuman Therapy EvaluationSamplingHematopoietic Stem CellsHematopoietic Stem Cell TransplantationProceduresBone Marrow TransplantationHomologous TransplantationClinically SignificantHistocompatibilityEventIn VitroMeasurementClinical TrialsGraft Versus Host DiseaseAnimal ModelClinical ResearchHuman ResourcesAcute Graft Versus Host Disease
Grant awards (15)
26th Annual Fanconi Anemia Research Fund Scientific Symposium$7,500
R13 · FY2014 · HL · contact PI
In vivo irradiations with patients undergoing radiation therapy: dana farber canc$194,128
U19 · FY2013 · AI · contact PI
In vivo irradiations with patients undergoing radiation therapy: dana farber canc$217,765
U19 · FY2012 · AI · contact PI
In vivo irradiations with patients undergoing radiation therapy: dana farber canc$217,801
U19 · FY2011 · AI · contact PI
Ex Vivo Alloanergization to Improve Immunity After Haploidentical Transplant$374,405
R21 · FY2010 · CA · contact PI
In vivo irradiations with patients undergoing radiation therapy: dana farber canc$280,516
U19 · FY2010 · AI · contact PI
Ex Vivo Alloanergization to Improve Immunity After Haploidentical Transplant$370,550
R21 · FY2009 · CA · contact PI
rBPI21 & Endotoxin-directed Innate Immunity in Stem Cell Transplantation$222,543
R21 · FY2009 · HL · contact PI
Clinical Core$1,116,738
U19 · FY2008 · CA · contact PI
rBPI21 & Endotoxin-directed Innate Immunity in Stem Cell Transplantation$266,305
R21 · FY2008 · HL · contact PI
CELLULAR CORRECTION OF CONGENITAL HEMATOPOIETIC DISORDERS$284,242
P50 · FY2002 · HL
CELLULAR CORRECTION OF CONGENITAL HEMATOPOIETIC DISORDERS$284,242
P50 · FY2001 · HL
CELLULAR CORRECTION OF CONGENITAL HEMATOPOIETIC DISORDERS$284,242
P50 · FY2000 · HL
Centers For Clinical Research on TransplantaTION$0
N01 · FY2000 · HB
Centers For Clinical Research on TransplantaTION$0
N01 · FY2000 · HB